Extended-Spectrum β-Lactamase-Producing Escherichia coli in Neonates and Listeria monocytogenes in Young Children with Bacterial Meningitis in Japan

被引：8

作者：

Furuichi, Munehiro ^{[1
]}

Yaginuma, Mizuki ^{[1
]}

Shinjoh, Masayoshi ^{[1
]}

Ohnishi, Takuma ^{[1
]}

Takahashi, Takao ^{[1
]}

Iwata, Satoshi ^{[2
]}

机构：

[1] Keio Univ, Dept Pediat, Sch Med, 35 Shinanomachi,Shinjuku Ku, Tokyo 1608582, Japan

[2] Natl Canc Ctr, Dept Infect Dis, Tokyo, Japan

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2023年 / 12卷 / 03期

关键词：

bacterial meningitis; empiric treatment; ESBL-producing Escherichia coli; guideline; Listeria monocytogenes; INFLUENZAE TYPE-B; RECENT TRENDS;

D O I：

10.1093/jpids/piac135

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Nationwide surveillance of pediatric bacterial meningitis in Japan from 2019 to 2021 showed that most cases were covered by recommended empiric therapy, with two exceptions: ESBL-producing Escherichia coliin neonates and Listeria monocytogenesin young children. Nationwide surveillance of pediatric bacterial meningitis in Japan from 2019 to 2021 revealed two uncommon situations not covered by the recommended empiric treatment that were not rare in Japan, namely, extended-spectrum beta-lactamase-producing-producing Escherichia coli in neonates and Listeria monocytogenes in children older than 1 month.

引用

页码：165 / 168

页数：4

共 15 条

[11] Antibiotic treatment and mortality in patients with Listeria monocytogenes meningitis or bacteraemia [J].